Pfizer Venture Investments - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2004
Pfizer Venture Investments focuses on life science investments in areas of strategic interest to Pfizer. The firm targets emerging companies developing transformative medicines and technologies that could enhance Pfizer's pipeline and shape the future of the industry. Investments typically range from Series A to Series C rounds, with occasional participation in later stages.
Notable portfolio companies include Kymera Therapeutics, Nimbus Therapeutics, and SpringWorks Therapeutics. Pfizer Ventures actively supports its portfolio companies, leveraging Pfizer's extensive resources and expertise in drug discovery, clinical development, and commercialization. The firm aims to remain at the forefront of life science advances, identifying and investing in innovative companies with the potential to drive significant advancements in healthcare.
Pfizer Venture Investments - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages